Pharmaceutical Formulations Comprising Tenofovir And Emtricitabine

Patent No. EP3316868 (titled "Pharmaceutical Formulations Comprising Tenofovir And Emtricitabine") was filed by Gilead Sciences on Jun 29, 2016. The application was issued on Feb 19, 2020.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
TEVA PHARMACEUTICAL INDUSTRIES LTD	Nov 19, 2020	D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Aug 29, 2022
Communication to the parties concerning termination of the opposition proceedings - opposition rejected - no appeal lodged
Aug 29, 2022
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Aug 24, 2022
Termination of the opposition proceedings with maintenance of patent
Jun 7, 2022
(Electronic) Receipt
Jun 7, 2022
Advice of delivery
Jun 7, 2022
Letter accompanying subsequently filed items
Jun 1, 2022
Advice of delivery
May 13, 2022
Decision of the Opposition Division and instruction
May 13, 2022
Decision rejecting the opposition
May 13, 2022
Decision rejecting the opposition
May 13, 2022
Grounds for the decision (Annex) - opposition
May 13, 2022
Means of redress
May 13, 2022
Transmittal of decision / summons - opposition
May 13, 2022
Transmittal of decision / summons - opposition
Apr 22, 2022
Notification concerning the date of oral proceedings
Apr 22, 2022
Notification concerning the date of oral proceedings
Apr 21, 2022
Brief communication - Opposition proceedings
Apr 21, 2022
Brief communication - Opposition proceedings
Apr 14, 2022
(Electronic) Receipt
Apr 14, 2022
(Electronic) Receipt
Apr 14, 2022
Letter accompanying subsequently filed items
Apr 14, 2022
Letter accompanying subsequently filed items
Apr 14, 2022
Written submission in preparation to/during oral proceedings
Apr 14, 2022
Written submission in preparation to/during oral proceedings
Apr 13, 2022
Notification concerning the date of oral proceedings
Apr 13, 2022
Notification concerning the date of oral proceedings
Nov 8, 2021
Brief communication - Opposition proceedings
Nov 8, 2021
Brief communication - Opposition proceedings
Oct 19, 2021
Communication of amended entries
Oct 8, 2021
Letter accompanying subsequently filed items
Oct 8, 2021
Request for a change of address - opponent
Sep 2, 2021
(Electronic) Receipt
Sep 2, 2021
Advice of delivery
Sep 2, 2021
Letter accompanying subsequently filed items
Aug 25, 2021
Advice of delivery
Aug 20, 2021
Annex to the communication - opposition
Aug 20, 2021
Information concerning oral proceedings
Aug 20, 2021
Summons to attend oral proceedings
Aug 20, 2021
Summons to attend oral proceedings
Aug 20, 2021
Transmittal of decision / summons - opposition
Aug 20, 2021
Transmittal of decision / summons - opposition
Apr 19, 2021
Brief communication - Opposition proceedings
Apr 13, 2021
(Electronic) Receipt
Apr 13, 2021
Auxiliary request during Opposition procedure
Apr 13, 2021
Auxiliary request during Opposition procedure
Apr 13, 2021
Auxiliary request during Opposition procedure
Apr 13, 2021
Auxiliary request during Opposition procedure
Apr 13, 2021
Auxiliary request during Opposition procedure
Apr 13, 2021
Auxiliary request during Opposition procedure
Apr 13, 2021
Auxiliary request during Opposition procedure
Apr 13, 2021
Auxiliary request during Opposition procedure
Apr 13, 2021
Auxiliary request during Opposition procedure
Apr 13, 2021
Auxiliary request during Opposition procedure - 01
Apr 13, 2021
Auxiliary request during Opposition procedure - 02
Apr 13, 2021
Auxiliary request during Opposition procedure - 03
Apr 13, 2021
Auxiliary request during Opposition procedure - 04
Apr 13, 2021
Auxiliary request during Opposition procedure - 05
Apr 13, 2021
Auxiliary request during Opposition procedure - 06
Apr 13, 2021
Auxiliary request during Opposition procedure - 07
Apr 13, 2021
Auxiliary request during Opposition procedure - 08
Apr 13, 2021
Auxiliary request during Opposition procedure - 09
Apr 13, 2021
Citation in opposition procedure - 014
Apr 13, 2021
Consolidated list of cited opposition documents
Apr 13, 2021
Letter accompanying subsequently filed items
Apr 13, 2021
Reply of the patent proprietor to the notice(s) of opposition
Dec 3, 2020
Communication of a notice of opposition and request to file observations
Dec 3, 2020
Notice of further oppositions to opponent(s)
Nov 26, 2020
Communication of a notice of opposition - first information to patent proprietor
Nov 19, 2020
(Electronic) Receipt
Nov 19, 2020
Citation in opposition procedure - 001
Nov 19, 2020
Citation in opposition procedure - 002
Nov 19, 2020
Citation in opposition procedure - 003
Nov 19, 2020
Citation in opposition procedure - 004
Nov 19, 2020
Citation in opposition procedure - 005
Nov 19, 2020
Citation in opposition procedure - 006
Nov 19, 2020
Citation in opposition procedure - 007
Nov 19, 2020
Citation in opposition procedure - 008
Nov 19, 2020
Citation in opposition procedure - 009
Nov 19, 2020
Citation in opposition procedure - 010
Nov 19, 2020
Citation in opposition procedure - 011
Nov 19, 2020
Citation in opposition procedure - 012
Nov 19, 2020
Citation in opposition procedure - 013
Nov 19, 2020
Notice of opposition
Nov 19, 2020
Notice of opposition
Mar 2, 2020
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jan 23, 2020
Decision to grant a European patent
Jan 9, 2020
(Electronic) Receipt
Jan 9, 2020
Filing of the translations of the claims
Jan 9, 2020
French translation of claims
Jan 9, 2020
German translation of the claims
Jan 9, 2020
Letter accompanying subsequently filed items
Sep 18, 2019
Bibliographic data of the European patent application
Sep 18, 2019
Communication about intention to grant a European patent
Sep 18, 2019
Intention to grant (signatures)
Sep 18, 2019
Text intended for grant (clean copy)
Sep 18, 2019
Text intended for grant (version for approval)
Jul 30, 2019
(Electronic) Receipt
Jul 30, 2019
Amended claims with annotations
Jul 30, 2019
Amended description with annotations
Jul 30, 2019
Claims
Jul 30, 2019
Description
Jul 30, 2019
Letter accompanying subsequently filed items
Jul 30, 2019
Reply to communication from the Examining Division
Jul 9, 2019
Annex to the communication
Jul 9, 2019
Communication from the Examining Division
Jul 3, 2019
Examination started
Jan 3, 2019
Decision to allow further processing
Dec 12, 2018
(Electronic) Receipt
Dec 12, 2018
Amended claims filed after receipt of (European) search report
Dec 12, 2018
Letter accompanying subsequently filed items
Dec 12, 2018
Request for further processing
Oct 2, 2018
Claim deemed abandoned
Aug 20, 2018
(Electronic) Receipt
Aug 20, 2018
Amended description filed after receipt of (European) search report
Aug 20, 2018
Amendments received before examination
Aug 20, 2018
Letter accompanying subsequently filed items
Apr 11, 2018
Notification on forthcoming publication of bibliographic data
Feb 9, 2018
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Feb 7, 2018
Communication to designated inventor
Feb 7, 2018
Communication to designated inventor
Jan 24, 2018
(Electronic) Receipt
Jan 24, 2018
Request for entry into the European phase
Jan 16, 2018
Copy of the international preliminary report on patentability
Nov 10, 2017
Information on entry into European phase
Jan 23, 2017
Priority document (electronically transmitted)
Jan 23, 2017
Priority document (electronically transmitted)
Jan 23, 2017
Priority document (electronically transmitted)
Jan 23, 2017
Priority document (electronically transmitted)
Jan 5, 2017
Copy of the international search report
Jan 5, 2017
Published international application - A1
Sep 23, 2016
Written opinion of the ISA, boxes No. I to VIII
Sep 23, 2016
Written opinion of the ISA, cover sheet
Sep 23, 2016
Written opinion of the ISA, supplemental box
Aug 25, 2016
Annex
Aug 25, 2016
Incoming letter related to ISA procedure
Aug 25, 2016
Notification Concerning Payment of Prescribed Fees (copy for ISA/EP)
Aug 25, 2016
Substitute sheet (Rule 26) - request form for ISA/EP
Aug 2, 2016
Notification of receipt of Search copy
Jul 18, 2016
Abstract
Jul 18, 2016
Annex
Jul 18, 2016
Claims
Jul 18, 2016
Description
Jul 18, 2016
Drawings
Jul 18, 2016
Fee calculation sheet for an international application
Jul 18, 2016
Notification Concerning Payment of Prescribed Fees (copy for ISA/EP)
Jul 18, 2016
Notification of the International Application Number and of the International Filing Date (copy for ISA/EP)
Jul 18, 2016
Request form for international application (copy for ISA/EP)

EP3316868

GILEAD SCIENCES

Application Number: EP16739625A
Filing Date: Jun 29, 2016
Status: Opposition Rejected; Aug 26, 2022
Publication Date: Feb 19, 2020
External Links: Slate, Register , Google Patents

IP Verse

Pharmaceutical Formulations Comprising Tenofovir And Emtricitabine

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3316868